Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Chemotherapy Drug Shortages in Pediatric Oncology, With Drs. Sarah Tasian and Yoram Unguru

Chemotherapy Drug Shortages in Pediatric Oncology, With Drs. Sarah Tasian and Yoram Unguru

FromThe Hematologist


Chemotherapy Drug Shortages in Pediatric Oncology, With Drs. Sarah Tasian and Yoram Unguru

FromThe Hematologist

ratings:
Length:
20 minutes
Released:
Jun 28, 2021
Format:
Podcast episode

Description

In this podcast, Contributing Editor Dr. Sarah Tasian has a conversation with Dr. Yoram Unguru. They discuss Dr. Tasian’s Feature article from the July/August 2021 issue of The Hematologist, titled, "Chemotherapy Drug Shortages in Pediatric Oncology: A Global Public Health Crisis Threatening Our Children." They shed light on chemotherapy drug shortages currently affecting pediatric cancer patients. You can access her Feature article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021412/476169/Chemotherapy-Drug-Shortages-in-Pediatric-Oncology.
Additional ASH affiliation and COI information: Dr. Sarah Tasian serves on the Educational Program Advisory Panel for the 2021 ASH Annual Meeting and is a member of the Scientific Committee on Blood Disorders in Childhood. Dr. Tasian receives/d research funding from Incyte Corporation and Gilead Sciences and serves on the scientific advisory boards for Aleta Biotherapeutics and Kura Oncology.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Jun 28, 2021
Format:
Podcast episode

Titles in the series (100)

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.